Advos

China has implemented an AI model at a major renewable energy base to address output instability, offering lessons for companies like GeoSolar Technologies.

As AI capabilities expand, experts emphasize that the primary cybersecurity risk stems from malicious human actors exploiting AI, prompting platforms like Coinbase to bolster defenses.

Researchers at the University of Manchester have discovered that a subset of immune cells, often overlooked, is essential for mobilizing the immune system to attack and sustain the fight against cancer, with potential implications for companies like Calidi Biotherapeutics.

Despite tech leaders' claims that AI will reduce work hours, evidence from inside AI companies suggests employees are working more, not less, raising concerns about the true impact of AI on the workforce.

A fund manager's forecast that gold may reach $5,000 an ounce in the coming years highlights the metal's long-term potential and supports continued investment in exploration projects.

Robinhood has begun offering crypto trading to eligible UK customers, providing access to over 50 tokens through its app, a move that could boost mainstream adoption and benefit the broader crypto industry.

Sales of Chinese electric vehicles in Europe soared in the first five months of 2026, increasing their market share by 5% and signaling a major shift in the European auto market.

Apple is reportedly considering using storage and memory chips from Chinese manufacturer CXMF to mitigate supply shortages caused by the AI boom, initially for products sold in China, a move that could impact the global memory chip market and competitors like Micron.

Quantum BioPharma reported a 53% reduction in operating expenses and received FDA approval to begin Phase 2 trials for its multiple sclerosis drug Lucid-MS, positioning the company for potential breakthroughs in progressive MS treatment.

Regentis Biomaterials is simultaneously progressing its GelrinC cartilage repair product through US clinical trials and European commercialization, with manufacturing scale-up, potentially accelerating market availability.

Safe Pro Group's AI-driven revenue surged over 3,000% in Q2 2026, driven by U.S. government contracts, highlighting the growing demand for AI-powered defense solutions.

American Fusion Inc. updates investors on rising electricity demand and its strategy to commercialize the Texatron Fusion Engine, potentially impacting the energy industry's approach to distributed power.

Outamation's first Inc. 5000 ranking highlights its rapid growth by automating document-heavy mortgage workflows, with a focus on compliance and responsible AI.

HeartBeam reports Q2 2026 results, showing progress in its heart attack detection program and commercial launch, with cash runway extended into 2027.

AZIO AI Holdings is advancing a 500-megawatt AI data-center campus in Texas, addressing critical power and connectivity constraints that threaten AI expansion.

Datavault AI hires Dean Becker, a seasoned intellectual property executive, to lead licensing and monetization of its global IP portfolio, a move that could significantly enhance revenue from its advanced technologies.

Lantern Pharma reported Q2 2026 results, highlighting progress in its AI-driven oncology pipeline and the establishment of Open Medicine AI as a separate company, with significant clinical and regulatory advancements.

Redwood AI Corp. has finalized its acquisition of Quantum.IQ Technologies, adding quantum-readiness assessment and cryptographic visibility to its AI-driven technology suite.

Helus Pharma reports progress in its Phase 3 program for HLP003 in major depressive disorder, with topline data expected in Q4 2026, and provides financial results for the second quarter.

Royalty Management Holding Corporation announced a 38% revenue increase and net income of $375,000 for Q2 2026, driven by its environmental services segment and early royalties from ReElement Technologies, signaling a turnaround from prior-year losses.